Venous Thromboembolism: Diagnosis and Treatment

Area of Science:

• Cardiovascular Medicine
• Hematology
• Diagnostic Imaging

Background:

• Venous thromboembolism (VTE), encompassing deep venous thrombosis (DVT) and pulmonary embolism (PE), is a significant cause of cardiovascular mortality.
• Accurate risk stratification and diagnosis are crucial for effective VTE management.

Purpose of the Study:

• To outline current diagnostic strategies for VTE, including clinical prediction rules and imaging modalities.
• To review contemporary therapeutic recommendations for VTE, emphasizing outpatient management and anticoagulant choices.
• To discuss considerations for secondary VTE prevention.

Main Methods:

• Utilized clinical prediction rules (Wells' Criteria, PERC) to assess pretest probability for DVT and PE.
• Employed D-dimer assays for ruling out VTE in low-to-moderate risk patients.
• Described diagnostic imaging techniques including compression ultrasonography for DVT and CT pulmonary angiography or V/Q scans for PE.
• Reviewed evidence for direct-acting oral anticoagulants (DOACs) versus traditional anticoagulants for VTE treatment.

Main Results:

• DOACs are preferred for outpatient VTE therapy, with apixaban or rivaroxaban suitable for initial management without parenteral bridging.
• Most acute uncomplicated DVTs can be managed on an outpatient basis.
• Treatment duration is typically 3 to 6 months, with extended secondary prevention considered for high-risk patients.

Conclusions:

• VTE diagnosis relies on a combination of clinical assessment, risk scores, and appropriate imaging.
• DOACs represent a preferred and effective therapeutic option for VTE, facilitating outpatient management.
• Secondary prevention strategies should be individualized based on VTE recurrence risk and bleeding assessment.